GlassScriptPhysician profile
Peter H Connolly
NPI 1104066356
$13,000.61
in general payments reported to CMS, 2019-2025
27 companies · $1,025 in 2025
The $1,025 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $3,883 · 2020: $3,047 · 2021: $825 · 2022: $1,781 · 2023: $1,254 · 2024: $1,185 · 2025: $1,025.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,401 · Travel and Lodging: $62.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,400.85 |
| Travel and Lodging | $62.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $5,993.86 | 2019-2025 | Ruby Coil, Penumbra System |
| W. L. Gore & Associates, INC. | $2,439.56 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Cook Medical LLC | $1,194.86 | 2019-2025 | Zenith Alpha, Zenith Spiral-Z, Zilver Ptx |
| Silk Road Medical, INC. | $844.63 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Smith+Nephew, INC. | $446.28 | 2019-2024 | Pico 7, Pico, Collagenase Santyl |
| Boston Scientific Corporation | $367.53 | 2021-2025 | Enroute Transcarotid Neuroprotection System, 2cm Peripheral Cutting Balloon |
| Tactile Systems Technology INC | $245.57 | 2019-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Abbott Laboratories | $211.32 | 2022-2023 | Jeti Peripheral Catheter |
| Medtronic Vascular, INC. | $203.00 | 2019 | |
| Endologix LLC | $168.20 | 2025 | Endocross Device, Torus Stent Graft System |
| Davol INC. | $148.42 | 2021 | |
| Bard Peripheral Vascular, INC. | $120.62 | 2024 | Rotarexs 6 F X 135 Cm |
| Abbvie INC. | $113.87 | 2023-2025 | Dalvance |
| Acell, INC. | $101.69 | 2019 | |
| Janssen Pharmaceuticals, INC | $95.06 | 2019-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $90.97 | 2025 | Novosorb Btm |
| Balt USA, LLC | $35.45 | 2024 | Prestige Coil System |
| Cagent Vascular INC | $33.73 | 2023-2024 | Serrantor |
| Kci USA, INC. | $27.08 | 2023 | Prevena, V.A.C.Ulta, V.A.C. Veraflo |
| Misonix INC | $26.30 | 2021 | |
| Lemaitre Vascular, INC. | $25.12 | 2023 | Hydro Lemaitre Valvulotome |
| E.R. Squibb & Sons, L.L.C. | $23.77 | 2022 | |
| Teleflex LLC | $15.77 | 2020 | |
| Melinta Therapeutics, LLC | $14.58 | 2023 | Orbactiv, Kimyrsa |
| Mimedx Group, INC. | $13.37 | 2024 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$3,400.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Connolly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.